Table 1.

Demographic and clinical characteristics.

	PD (N = 16)	ET (N = 16)	P value
Gender (male %)	50%	81.2%	0.13
Age (mean, SD)	71.3 ± 6.3	68.3 ± 12.3	0.29
Years of evolution (mean, SD)	7.1 ± 3.4	21.1 ± 15.2	0.001
Clinical phenotype (%)	Rigid akinetic 6.25% Tremor-dominant 37.5% Mixed phenotype 56.3%	Classic presentation 100% + Head tremor 31.2% + Voice tremor 6.2% + Perioral tremor 6.2%	–
Clinical scale (mean, SD)	Hoehn and Yahr 1.94 ± 0.54 MDS-UPDRS III 22.1 ± 9.7	Fahn–Tolosa–Marin scale 16.25 ± 10.9	–
Treatment	L-DOPA 93.7% Dopamine agonist 56.25% Monoamine oxidase inhibitors 31.25%	Propranolol 31.3% Propanolol + benzodiazepine 12.5%	–

PD: Parkinson’s disease; ET: essential tremor; L-DOPA: levodopa.